NCT06650709 NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study Status NOT_YET_RECRUITING Phase PHASE2
NCT06646419 Boosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06644924 A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma Status COMPLETED Phase PHASE2
NCT06639997 Safety and Tolerability of AZD5148 in Japanese Participants Status COMPLETED Phase PHASE1
NCT06639087 A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal Impairment Status TERMINATED Phase PHASE1
NCT06635499 VITALIZE.Use and Effectiveness of Sodium Zirconium Cyclosilicate (LokelmaTM) in the Real-world Setting in Spain Status COMPLETED Phase N/A
NCT06635447 Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06634056 Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation Status NOT_YET_RECRUITING Phase PHASE2
NCT06633536 Real-life Treatment Outcomes of Ravulizumab in PNH Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06630325 A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT06627647 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC Status RECRUITING Phase PHASE3
NCT06613516 Effect of Capivasertib on ctDNA in ER Positive Breast Cancer Status WITHDRAWN Phase PHASE2
NCT06611423 AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment Status TERMINATED Phase PHASE1
NCT06611345 A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers Status RECRUITING Phase NA
NCT06610526 A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06607757 Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer Status RECRUITING Phase PHASE2
NCT06607393 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3] Status COMPLETED Phase N/A